The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2015

Filed:

Mar. 12, 2009
Applicants:

Ryuichi Morishita, Osaka, JP;

Hironori Nakagami, Osaka, JP;

Takashi Miyake, Osaka, JP;

Makoto Mitamura, Osaka, JP;

Hiroaki Nakajima, Tokyo, JP;

Hiroaki Matsuda, Tokyo, JP;

Nao Suizu, Miyazaki, JP;

Yoshihumi Kawano, Miyazaki, JP;

Kunihiko Takagi, Miyazaki, JP;

Hiroyuki Tsujimoto, Osaka, JP;

Yusuke Tsukada, Osaka, JP;

Kaori Hara, Osaka, JP;

Yohei Bando, Osaka, JP;

Inventors:

Ryuichi Morishita, Osaka, JP;

Hironori Nakagami, Osaka, JP;

Takashi Miyake, Osaka, JP;

Makoto Mitamura, Osaka, JP;

Hiroaki Nakajima, Tokyo, JP;

Hiroaki Matsuda, Tokyo, JP;

Nao Suizu, Miyazaki, JP;

Yoshihumi Kawano, Miyazaki, JP;

Kunihiko Takagi, Miyazaki, JP;

Hiroyuki Tsujimoto, Osaka, JP;

Yusuke Tsukada, Osaka, JP;

Kaori Hara, Osaka, JP;

Yohei Bando, Osaka, JP;

Assignees:

AnGes MG, Inc., Osaka, JP;

Medikit Co., Ltd., Tokyo, JP;

Hosokawa Micron Corporation, Osaka, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 29/16 (2006.01); A61M 25/10 (2013.01); B05D 5/00 (2006.01); A61L 29/08 (2006.01); A61M 25/00 (2006.01);
U.S. Cl.
CPC ...
A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61M 25/0045 (2013.01); A61M 25/10 (2013.01); A61M 25/104 (2013.01); A61M 25/1027 (2013.01); A61L 2300/258 (2013.01); A61L 2300/624 (2013.01); A61L 2400/12 (2013.01); A61M 2025/0057 (2013.01); A61M 2025/105 (2013.01); A61M 2025/1031 (2013.01); A61M 2025/1075 (2013.01); A61M 2025/1086 (2013.01);
Abstract

Biocompatible nanoparticleswhich entrap a bioactive substance and whose surface is positive-charge-modified are electrically adhered to a balloon portionof a catheter main bodythrough a negatively charged resin layer, and thus a nanoparticle layeris formed. After the catheter main bodyis indwell in vivo, the nanoparticlesare gradually eluted from the nanoparticle layerand are effectively delivered to cells.


Find Patent Forward Citations

Loading…